Global expansion Medicoms global footprint across 50 countries and 10 manufacturing plants in North America, Europe and Asia indicates a mature distribution network and potential for cross-border supply contracts, regional partnerships, and multi-country procurement programs.

Nitrile capacity Recent investments to build Canada’s first medical-grade nitrile glove plant and expansion of production facilities in the UK and Europe signal strong capacity growth and potential upsell opportunities for large health systems and distributors seeking reliable nitrile glove supply.

Infection control focus A broad portfolio spanning infection control, single-use and preventive products for medical, dental, industrial and veterinary markets creates cross-sell opportunities to existing customers and adjacent markets seeking integrated infection prevention solutions.

Public funding leverage Significant government funding support for expansion, including Strategic Innovation Fund contributions, suggests Medicom has favorable capacity expansion timelines and potential for public-private partnerships, security of supply, and government procurement channels.

Industry credibility Recognition as a Canada’s Best Managed Company and a history of supplying during past epidemics reinforces credibility with large buyers, distributors and healthcare providers, enabling easier procurement conversations and trusted supplier relationships.